Ligand · I2L
I2L · 2-[4,8-dimethyl-2-oxidanylidene-7-[[3-(trifluoromethyl)phenyl]methoxy]chromen-3-yl]ethanoic acid
I2L, 2-[4,8-dimethyl-2-oxidanylidene-7-[[3-(trifluoromethyl)phenyl]methoxy]chromen-3-yl]ethanoic acid (C21 H17 F3 O5, 406.4 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site with its…
- Component
- I2L
- Formula
- C21 H17 F3 O5
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
I2L in 1 structure; the first of them:
- 7XUH · Down-regulated in adenoma in complex with TQR1122 · I2L A1001 · binds PHE130, PRO131, ILE132, LEU205, ILE210, PHE213, THR214, VAL349 and 9 more
Residues it binds most
LEU 2, ALA 2, ILE 2, PHE 2, SER 2, VAL 2, ASN 2, MET 2, PRO 2, THR 2 (residue and the binding sites it lines).
Found with
- Y01 · Cholesterol hemisuccinate
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.